Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WuXi AppTec
Pharma
AstraZeneca-Alteogen, Taiho, WuXi—Fierce Pharma Asia
AZ taps Alteogen to develop subcutaneous cancer drugs. Taiho acquires ADC expert Araris Biotech. WuXi AppTec expects sales growth in 2025. And more.
Angus Liu
Mar 21, 2025 9:10am
WuXi AppTec offers rosy 2025 guidance despite US-China tensions
Mar 18, 2025 4:30pm
Takeda, AZ-Daiichi, Fosun-Henlius—Fierce Pharma Asia
Jan 24, 2025 8:55am
In €500M deal, Merck buys Ireland vaccines plant from WuXi Bio
Jan 6, 2025 11:36am
Biosecure's chances look slim after omission from defense bill
Dec 9, 2024 11:43am
AstraZeneca, GSK, Takeda—Fierce Pharma Asia
Nov 1, 2024 8:20am
